Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 18/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 18/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 16/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | KMO | O15229 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24749733 | 0.85 | ALDH1A1 (0.59) | HTR2ASLC6A4KCNH2HSP90AA1 | |
| SCHEMBL31694884 | 0.85 | ALDH1A1 (0.59) | HTR2ASLC6A4KCNH2HSP90AA1 | |
| SCHEMBL10269448 | 0.85 | AR (0.54) | HTR2ASLC6A4KCNH2 | |
| SCHEMBL11175966 | 0.83 | HSP90AA1 (0.57) | HTR2ASLC6A4KCNH2HSP90AA1SLC6A2 | |
| SCHEMBL31287771 | 0.83 | HSP90AA1 (0.57) | HTR2ASLC6A4KCNH2HSP90AA1SLC6A2 | |
| SCHEMBL5540628 | 0.83 | SLC6A4 (0.40) | HTR2ASLC6A4KCNH2HSP90AA1SLC6A2 | |
| SCHEMBL197088 | 0.83 | CA12 (0.62) | HTR2ASLC6A4SLC6A2SLC6A3 | |
| SCHEMBL29587997 | 0.83 | CA12 (0.62) | HTR2ASLC6A4SLC6A2SLC6A3 | |
| SCHEMBL17791828 | 0.83 | BACE1 (0.47) | KMO | |
| SCHEMBL21820786 | 0.82 | HSP90AA1 (0.71) | HTR2ASLC6A4KCNH2HSP90AA1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7038021-B2 | Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same | KYOTO ELECTRONICS MANUFACTURING CO., LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| US-20050153378-A1 | Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same | KYOTO ELECTRONICS MANUFACTURING CO., LTD. (JP) | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050153378-A1 | Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same | DDT, CD2, TEAD4 | HTR2A 2719/4885SLC6A4 3567/4885KCNH2 1294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.